No significant relationship was observed between PPA1 expression and other clinicopathological factors, such as pathologic type, stage, histological grade, tumor site, presence of lymph node metastases, and gender in lung cancer (P > 0.05), or between subtype, age, and stage in ovarian cancer (P > 0.05). The gene discussed is PPA1; the disease is lung cancer.